Melanoma by the State: Oregon
…leads an all-front program called the War on Melanoma™, the goal of which is to eliminate melanoma as a cause…
Melanoma by the State: Oregon
…leads an all-front program called the War on Melanoma™, the goal of which is to eliminate melanoma as a cause…
,
In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here
…melanoma was not a part of the adjuvant therapy conversation, because melanoma was almost completely impervious to the various drugs…
,
Five Things You May Not Know About Bob Marley and Acral Lentiginous Melanoma
…factors apply to the far more common types of cutaneous (meaning “skin”) melanoma, such as superficial spreading melanoma, not acral…
,
Worried Your Immunotherapy Isn’t Working: The Role of Imaging and ctDNA
…Patient Education Videos How Tumor Genetics Inform Melanoma Care Advances in genetics are transforming the way we understand and treat…
Melanoma by the State: North Carolina
…families, and friends updates on advances in melanoma. This valuable annual event, now in its fourth decade, continues to serve…
,
Men and Women and Melanoma: Who’s Winning the Battle?
…Day 2025, let’s delve into the differences between men and women and melanoma. Who’s winning the battle? It’s an Uneven…
From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness
…when she did finally look at it closely, she felt a sharp pang of fear. Her mind flashed to memories…
,
You’re Not Out of Options: What to Do When First-Line Melanoma Treatment Fails
…melanoma response. Blood markers: LDH and ctDNA are discussed but currently not reliable for routine monitoring in melanoma. Biopsy: Occasionally…
,
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
…patients with melanoma were studied. There were 14 patients with cutaneous melanoma, 16 patients with uveal melanoma, 2 patients with…
,
In Plain English: The Results of DreamSeq
…targeted therapy and initial treatment with immunotherapy. BRAF Mutant Melanoma There are actually several types of BRAF mutation in melanoma…
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026